Treasurer Archives - European Industrial Pharmacists Group (EIPG)

A concept paper on the revision of Annex 11


This concept paper addresses the need to update Annex 11, Computerised Systems, of the Good Manufacturing Practice (GMP) guideline. Annex 11 is common to the member states of the European Union (EU)/European Economic Area (EEA) as well as to Read more

What happens after IP loss of protection


by Giuliana Miglierini What does it happen under a competitiveness perspective once intellectual property (IP) protection for medicinal products expired? And what is the impact of the new entries on generics and biosimilars already in the market? The role of competitor Read more

The FDA warns about the manufacture medicinal and non-pharmaceutical products on the same equipment


by Giuliana Miglierini A Warning Letter, sent in September 2022 by the US FDA to a German company after an inspection, addresses the possibility to use the same equipment for the manufacturing of pharmaceutical and non-pharmaceutical products. The FDA reject Read more

General Assembly 2022: Bureau elections

, , , , , ,

At the General Assembly held on October 15-16 in Athens, voting took place for the positions of EIPG President and Vice-President of Technical and Professional Development.

The delegates present at this annual meeting elected Piero Iamartino as President for the next three-year mandate. Rebecca Stanbrook was elected to the position of Vice-President of Technical and Professional Development. Brigitte Saunier completed her term of office as Treasurer and was thanked for her valuable support. Maurizio Battistini, Vice-President of European Affairs will act as EIPG Treasurer until the next General Assembly.

Claude Farrugia who has been President for two mandates and previously Vice -President of Communications was warmly thanked for his significant contribution to the progress EIPG has made in recent years as a reputable professional association recognised by the European Health Authorities.

The new President together with the current Vice-Presidents highlighted their main strategic objectives confirming their full commitment to developing and promoting the position of the industrial pharmacist in Europe.